CD5, CD7, and CD30 expression levels in PTCL were 85%, 50%, and 16%, respectively; in AITL, 96%, 57%, and 32–50%, respectively; in ALCL, 30%, 32–54%, and 93%, respectively [46]. Here, TNFRSF8 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.